AzTrials
AzTrials

Aortic Stenosis3DP-FASTNCT05484713

Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure

An observational study of Aortic Stenosis and Valvular Cardiomyopathy, run by Cardio Med Medical Center at 1 site in Romania.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of 3DP-FAST study is to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure. Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Cardiac imaging and 3D printing of the aortic valve
Type of treatment
Medical device
How many people
20 participants
Where
1 siteRomania
Study dates
8 Jul 2022to Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients with a minimum age of 60 years old, with severe degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs, and who do not require the criteria for surgical aortic valve replacement.

Who may be able to join

  • patients with degenerative aortic stenosis who present the criteria for transcatheter aortic valve intervention, who undergo coronary CCTA and CT angiography of the abdominal aorta and lower limbs.

Who cannot join

  • contraindications for TAVI procedures
  • patients that undergo surgical aortic valve replacement for aortic stenosis
  • patients with contraindications for iodine contrast agent administration (acute renal failure, allergy, thyroid dysfunction).
  • other conditions associated with suboptimal CCTA image acquisition which could interfere with CT image postprocessing for creation of 3D printed models.

Trial locations and contacts

1 site in 1 country.

Daniel Cernica, MD contact

+40 265 217 333

daniel.cernica@gmail.com

Theodora Benedek, Professor contact

+40 265 217 333

theodora.benedek@gmail.com

Romania1 site, 1 recruiting
  • Cardio Med Medical Center

    Târgu Mureş, 540124

    Theodora Benedek, PhD, MD, +40-265-217-333, theodora.benedek@gmail.com

    Recruiting

Other trials in Romania

About this study

Official title: Feasibility of 3D Printed Models of Aortic Stenosis in Guiding TAVI Procedure -the 3DP-FAST Study

  • The aim of 3DP-FAST study is to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure. By conducting a comparative analysis of measurements achieved on CCTA images versus measurements obtained with a specialized projection platform by photogrammetry vs 3D printed models of various aortic valvular and perivalvular structures will be evaluated the accuracy of each step of image dataset processing. Furthermore, the study will evaluate the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block based on coronary computed tomography angiographic and ECG assessment at 1 year after enrollment.
Read the detailed description

The project is a prospective, cohort, mono-centric study which will be carried out in CardioMed Medical Center in collaboration with the University of Medicine, Pharmacy, Science and Technology "George Emil Palade" of Târgu Mureș.

The project will include 20 subjects who present severe aortic stenosis prior to study enrollment.

Diagnosis of severe aortic stenosis (AS) as determined by echocardiography, who are deemed eligible for TAVI by the Center of Advanced Research in Multimodal Cardiac Imaging Cardiomed Heart Valve Team.

All patients will undergo coronary CT angiography, cardiac perfusion CT and peripheral CT angiography at the moment of enrollment in the study, for complex assessment of aortic valvular and perivalvular structures as well as for peripheral vascular approach.

The study will be conducted over a period of 1 year, in which patients will be examined at baseline, and during follow-up visit. At the one-year follow-up, the study subjects will undergo CT coronary angiography for re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block. In case of non-presentation for the follow-up visit, patients will be contacted via telephone by one of the investigators, and questioned about the general health status, occurrence of cardiovascular or cerebrovascular symptoms and interventions, for possible non-cardiovascular related hospitalizations, as well as regarding the presence of aortic valvular disease rates/repeated interventions.

All patients will sign an informed written consent prior to being enrolled in the study. After the screening process, patients that do not present exclusion criteria will be enrolled in the study.

Study objectives:

Primary: to analyze the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure

Secondary: re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block.

Study Timeline:

Baseline (day 0)

  • Obtain and document consent from participant on study consent form.
  • Verify inclusion/exclusion criteria.
  • Obtain demographic information, medical history, medication history, alcohol and tobacco use history.
  • Record results of physical examinations and 12-lead ECG.
  • Imaging procedures: transthoracic 2-D echocardiography, 128-multislice CT angiography (CCTA)
  • 3d printed model by FDM technique based on CCTA
  • Evaluation of 3D printing workflow accuracy Visit 2 (month 6)
  • Follow-up after TAVI procedure
  • Record results of physical examinations, 12-lead ECG and medical history.
  • Imaging procedures: transthoracic 2-D echocardiography Final study visit (month 12)
  • Record results of physical examinations, 12-lead ECG and medical history.
  • Imaging procedures: transthoracic 2-D echocardiography, 128-multisclice CCTA
  • End-point evaluation.

Study procedures:

  • Clinical examination, medical history
  • 12-lead ECG
  • 2D transthoracic echocardiography with measurement of: cardiac diameters, volumes, valvular function and regurgitation, pressure gradients, pericardial fat thickness, pericardial effusion, left ventricular global and regional function and ejection fraction.
  • 128-multislice CT coronary angiography with the evaluation of: epicardial fat volume, coronary plaque burden, total and local calcium score, aortic valve, perivalvular aortic structures, peripheral iliac vessels, ascending and descending segments of aorta.
  • Processing of DICOM image dataset by performing segmentation and STL adjustments
  • Processing STL image dataset by performing CAD analysis and adjustments
  • Processing G-code image dataset and sending to 3d printing station
  • 3D printing of aortic model including perivalvular aortic structures using fused filaments method

Data collection: In a dedicated database that includes all patient information, demographics, medical history, medication, therapeutic procedures, information derived from imaging techniques (echocardiography, CT angiography, CT imaging post-processing and shear stress evaluation).

Being tested
Cardiac imaging, 3D printing of the aortic valve
Keywords
aortic stenosis, 3D printing, interventional planning, cardiovascular models, TAVI, Accuracy
Medical subject headings
Aortic Valve Stenosis, Aortic Valve Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cardiac imagingDiagnostic test

    Baseline - 2D transthoracic echocardiography, 128-multislice CT coronary angiography, CCTA of peripheral lower limbs vessels 12-months follow-up - 128-multislice CT coronary angiography with transthoracic echocardiography

  • 3D printing of the aortic valveDevice

    3D printing of the aortic valve based on CCTA image acquisition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of 3D printed models of aortic valves in guiding TAVI procedure

    Analysis of the accuracy of replicating cardiovascular anatomical structures using different techniques and to evaluate the feasibility of 3D printed models of aortic stenosis in guiding TAVI procedure.

    Measured: at baseline

  2. Rate of complications during 12 months follow-up of patients undergoing TAVI for aortic stenosis

    Re-evaluation of the aortic valve, in the prospects of analyzing the rate of valvular leak or peri-procedural complications such as embolic events or atrio-ventricular conduction block during a 12 months follow-up after TAVI procedure.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2022
  2. Study start8 Jul 2022
  3. Primary completionJul 2023 (estimated)
  4. Study completionJul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05484713
Sponsor's protocol ID
CM-G510-3DP
Acronym
3DP-FAST
Status last verified
Jul 2022
First submitted
30 Jul 2022
Last updated
16 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD that underlie results in a publication will be available for interested parties.

Publications

  • Cernica D, Benedek I, Polexa S, Tolescu C, Benedek T. 3D Printing-A Cutting Edge Technology for Treating Post-Infarction Patients. Life (Basel). 2021 Sep 1;11(9):910. doi: 10.3390/life11090910.

    PubMed 34575059
  • Benedek A, Cernica D, Mester A, Opincariu D, Hodas R, Rodean I, Keri J, Benedek T. Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis. Int J Mol Sci. 2019 May 25;20(10):2574. doi: 10.3390/ijms20102574.

    PubMed 31130624
  • Wang DD, Qian Z, Vukicevic M, Engelhardt S, Kheradvar A, Zhang C, Little SH, Verjans J, Comaniciu D, O'Neill WW, Vannan MA. 3D Printing, Computational Modeling, and Artificial Intelligence for Structural Heart Disease. JACC Cardiovasc Imaging. 2021 Jan;14(1):41-60. doi: 10.1016/j.jcmg.2019.12.022. Epub 2020 Aug 26.

    PubMed 32861647
  • Vukicevic M, Mosadegh B, Min JK, Little SH. Cardiac 3D Printing and its Future Directions. JACC Cardiovasc Imaging. 2017 Feb;10(2):171-184. doi: 10.1016/j.jcmg.2016.12.001.

    PubMed 28183437

Questions about this trial

What is this clinical trial studying?

An observational study of Aortic Stenosis and Valvular Cardiomyopathy, run by Cardio Med Medical Center at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Daniel Cernica, MD (+40 265 217 333, daniel.cernica@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of 3D printed models of aortic valves in guiding TAVI procedure (time frame: at baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05484713, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in